One of the most common reasons people in Chicago never participate in a clinical trial is not reluctance. It is uncertainty. They do not know what kinds of studies are actually available. They assume the studies that exist are not relevant to their situation. They have no clear picture of what ‘qualifying’ actually means –Â what the process involves, what is being looked for, and whether someone like them would realistically be considered.
This article is written to close that gap. It covers the types of clinical trials that American Research Center runs in Chicago, what each of these areas means in practical terms for potential participants, and exactly how to find out whether you qualify for a study that is currently active.
The Three Therapeutic Areas at American Research Center
1 Oncology
Some oncology studies are treatment trials - testing a new medication, a new combination of existing medications, or a new dosing approach. These involve participants who have a specific cancer diagnosis and are evaluating whether the investigational treatment is safe and effective.
Others are supportive care studies - looking at ways to manage the side effects of cancer treatment, improve quality of life for people living with cancer, or address symptoms that existing treatments do not adequately handle.
A further category includes studies focused on cancer survivors - people who have completed treatment and are living in remission, participating in research that helps the medical community understand long-term outcomes, recurrence risks, or the ongoing health needs of people after cancer treatment.
Some oncology studies also involve healthy volunteers or people without a cancer diagnosis - particularly studies that are looking at early detection methods, biomarkers, or preventive approaches.
The key point is this: if cancer has touched your life - whether as a current patient, a survivor, or someone with a family history who wants to contribute to research - there may be a study at ARC that is relevant to your situation. The only way to find out is to reach out and ask.
2 Central Nervous System (CNS)
Many people are surprised to learn that CNS clinical trials include studies for conditions that are often considered too common or too mild for formal research. Major depressive disorder, generalised anxiety disorder, and insomnia - conditions that affect millions of Americans and are often inadequately treated by existing medications - are active areas of clinical research.
CNS studies at ARC typically involve participants who have a specific diagnosed condition and are being treated or monitored as part of a research protocol. The process begins with a thorough assessment by ARC's clinical team to confirm eligibility - this includes a review of current diagnosis, treatment history, and any medications currently being taken.
For people living in Chicago's West Side communities, where access to specialist psychiatric care can be limited, participation in a CNS clinical trial at ARC provides access to clinical expertise, structured monitoring, and - in most cases - an investigational treatment that is not otherwise available. Participants receive compensation for their time and receive more frequent clinical contact than is typical in standard outpatient care.
3 Infectious Diseases
Infectious disease studies vary considerably in their design and participant requirements. Some involve people who are actively managing a chronic infectious condition - HIV-positive individuals, people with chronic hepatitis C - who are evaluating new treatment options. Others involve people who have recovered from an infectious illness and are participating in follow-up research. Some studies look at prevention - evaluating vaccines or preventive treatments in healthy individuals at higher risk of a specific infection.
For anyone living with HIV or hepatitis C in the Chicago area, clinical trial participation at ARC can provide access to investigational treatments that are not available through standard care, under the supervision of an experienced clinical team. For healthy individuals interested in contributing to infectious disease prevention research, vaccine studies and prevention trials offer a way to participate that does not require any existing health condition.
What ‘Qualifying’ Actually Means
Every clinical trial has a set of eligibility criteria –Â specific characteristics that a participant must meet to be enrolled in the study. These criteria exist for two reasons: scientific validity (ensuring the study population is appropriate for the research question being investigated) and participant safety (ensuring the study procedures are appropriate for each individual’s health status).
Eligibility criteria typically include some combination of the following: age range, specific diagnosis or health status, duration of diagnosis or treatment history, current medications, geographic location, and sometimes lifestyle factors relevant to the therapeutic area.
People are sometimes discouraged from enquiring about clinical trials because they assume they will not qualify. This assumption is often wrong –Â for two reasons.
First, eligibility criteria vary considerably between studies. A criterion that disqualifies a person from one study may be irrelevant to another study in the same therapeutic area. American Research Center runs multiple studies simultaneously, and a person who does not qualify for one active study may be a strong candidate for another.
Second, eligibility screening is a separate step from enrollment. Expressing interest and going through a screening visit does not commit anyone to participating in a study. It is an information-gathering process –Â for ARC’s clinical team to assess eligibility, and for the potential participant to understand whether the study is right for them. The screening visit costs nothing, creates no obligation, and frequently produces useful clinical information regardless of whether enrollment follows.
How to Find Out If You Qualify Right Now
The process at American Research Center is deliberately simple. It begins with a short online form –Â four fields that take under two minutes to complete. ARC’s clinical coordination team reviews the information and follows up with a brief phone call, usually within 24 hours, to ask a few initial questions.
This phone call is not an interrogation. It is a conversation. The coordinator asks basic health questions to understand whether any currently active study might be a potential match. If there is a potential match, they invite the caller to come in for a screening visit. If there is no current match, they often invite the caller to remain on file –Â so that when a relevant study opens, they can be contacted first.
The screening visit itself involves a review of health history, a physical assessment, and any laboratory or diagnostic tests that the study protocol requires. Depending on the study, results are available within the same visit or within a few days. There is no cost to the participant at any stage of this process.
If the screening confirms eligibility and the participant chooses to enroll, compensation for time and travel is provided throughout the study. The amount varies by study and is explained in full during the informed consent process –Â before any decision is made.
Who We Are Looking For Right Now
American Research Center is actively recruiting participants for studies across all three of our therapeutic areas. The specific studies open at any given time change as protocols open and close, which is why the best approach is always to reach out and have a direct conversation.
Generally, we are looking for Chicago-area adults who fall into one of the following categories:
- Adults with a current or recent cancer diagnosis who are interested in understanding their treatment options through clinical research
- Cancer survivors who are interested in contributing to research on long-term outcomes and quality of life after treatment
- Adults living with depression, anxiety, sleep disorders, or other CNS conditions who are open to evaluating investigational treatment options
- Adults managing HIV or chronic hepatitis C who are interested in exploring new treatment approaches under clinical supervision
- Healthy adults who are interested in contributing to preventive research, early detection studies, or vaccine trials in relevant therapeutic areas
You do not need to be referred by a doctor. You do not need health insurance. You do not need any previous experience with clinical research. You need to be an adult living in or near Chicago and willing to come in for an initial screening conversation.
Taking the Next Step
If anything in this article describes your situation –Â or the situation of someone you know –Â the right next step is to fill out our short interest form. It takes under two minutes. A member of our team will follow up with a call within 24 hours to answer your questions and explore whether a current study might be relevant.
There is no commitment at this stage. No cost. No obligation. Just a conversation about whether the research we are conducting might be a fit for where you are right now.
You can submit your interest at theamericanresearch.com or visit us at 5351 W. North Ave, Chicago, IL 60639.
If you want to understand more about what to expect before you come in, our earlier articles cover exactly that. Learn about the compensation participants receive, and read about what actually happens at a screening visit –Â so you know exactly what to expect before you arrive.
